Results

Total Results: 1,548 records

Showing results for "drugs".

361. Case Control Study | Digital Healthcare Research
     digital.ahrq.gov/research-method/case-control-study
     January 01, 2023 - Case Control Study Prediction of GutCheck NEC and its relation to severity of illness and measures of deterioration in necrotizing enterocolitis. Citation Gephart SM, Fleiner M, Msowoya A, Rothers J. Prediction of GutCheck NEC and its relation to severity of illness and measur…

362. Development and evaluation of an improved methodology for assessing adherence to evidence-based drug therapy guidelines using claims data. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/improving-quality-through-decision-support-evidence-based-pharmacotherapy-5
     January 01, 2023 - Development and evaluation of an improved methodology for assessing adherence to evidence-based drug therapy guidelines using claims data. Citation Kawamoto K, Allen LaPointe NM, Silvey GA, et al. Development and evaluation of an improved methodology for assessing adherence to evidence-based drug ther…

363. Gastrointestinal Disease | Digital Healthcare Research
     digital.ahrq.gov/medical-condition/gastrointestinal-disease
     January 01, 2023 - Gastrointestinal Disease Health IT-Generated PROs to Improve Outcomes in Cirrhosis - Final Report Citation Bajaj J. Health IT-Generated PROs to Improve Outcomes in Cirrhosis – Final Report. (Prepared by Virginia Commonwealth University under Grant No. R01 HS025412). Rockville,…

364. Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/improving-post-hospital-medication-management-older-adults-health-information/citation/adverse-drug-events-hospital-discharge-older-adults
     January 01, 2023 - Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications. Citation Kanaan AO, Donovan JL, Duchin NP, et al. Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications. …

365. Detection and prediction limits for identifying highly confusable drug names from experimental data. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/tools-optimizing-medication-safety-top-meds/citation/detection-and-prediction
     January 01, 2023 - Detection and prediction limits for identifying highly confusable drug names from experimental data. Citation Lambert BL, Bhaumik R, Zhao W, et al. Detection and prediction limits for identifying highly confusable drug names from experimental data. J Biopharm Stat 2016;26(2):365–85. PMID: 26011079. …

366. High override rate for opioid drug-allergy interaction alerts: current trends and recommendations for future. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/encoding-and-processing-patient-allergy-information-ehrs/citation/high
     January 01, 2023 - High override rate for opioid drug-allergy interaction alerts: current trends and recommendations for future. Citation Topaz M, Seger DL, Lai K, et al. High override rate for opioid drug-allergy interaction alerts: current trends and recommendations for future. Stud Health Technol Inform 2015;216:242-…

367. Layout 1 (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/09-0023-EF_bcma_0.pdf
     December 01, 2008 - One grantee reported that 35 percent of the drugs they received from manufacturers did not have labels

368. Using Barcode Medication Administration to Improve Quality and Safety (pdf file)
     digital.ahrq.gov/sites/default/files/docs/lesson/09-0023-ef-bcma.pdf
     December 01, 2008 - One grantee reported that 35 percent of the drugs they received from manufacturers did not have labels

369. The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/national-cost
     January 01, 2023 - The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States. Citation Slight SP, Seger DL, Franz C, et al. The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States. J…

370. Effects of self-empowered teams on rates of adverse drug events in primary care. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/systems-engineering-approach-improving-medication-safety-clinician-use-health-3
     January 01, 2023 - Effects of self-empowered teams on rates of adverse drug events in primary care. Citation Singh R, Anderson D, McLean-Plunkett E, et al. Effects of self-empowered teams on rates of adverse drug events in primary care. Int J Family Med 2012; 2012:374639. Epub 2012 Feb 16. Link Singh R, Anderson…

371. Medication Safety in Primary Care Practice -- Translating Research into Practice (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/medication_safety_in_primary_care_practice_translating_2010_pdf__2.pdf
     January 01, 2010 - Medication Safety in Primary Care Practice -- Translating Research into Practice 1 | Medication Safety in PriMary care Practice—tranSlating reSearch into Practice 2010 Grant Summary Medication Safety in Primary Care Practice—Translating Research into Practice Principal Investigator: Ornstein, Steven, M.D. …

372. Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/encoding-and-processing-patient-allergy-information-ehrs/citation/understanding
     January 01, 2024 - Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study. Citation Samarakoon U, Wolfson AR, Zhou L, Bassir F, Phillips E, Kroshinsky D, Cucka B, Biglione B, Phadke NA, Jaggers J, Byrne EC, Judd AD, Blumenthal KG. Understanding the patient expe…

373. A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/cross-sectional
     January 01, 2023 - A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement. Citation Slight SP, Beeler PE, Seger DL, et al. A cross-sectional observational study of high override rates of drug allergy alerts in inpatient …

374. Drug hypersensitivity reactions documented in electronic health records within a large health system. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/encoding-and-processing-patient-allergy-information-ehrs/citation/drug-hypersensitivity
     January 01, 2023 - Drug hypersensitivity reactions documented in electronic health records within a large health system. Citation Wong A, Seger DL, Lai KH, et al. Drug hypersensitivity reactions documented in electronic health records within a large health system. J Allergy Clin Immunol Pract. 2018 Dec 1. pii:S2213-219…

375. Boston Medical Center | Digital Healthcare Research
     digital.ahrq.gov/organization/boston-medical-center
     January 01, 2023 - Boston Medical Center Implementation and Dissemination of 'Gabby,' a Health Information Technology System for Young Women, Into Community-Based Clinical Sites Description This research evaluated the appropriateness, acceptability, feasibility, and effectiveness of the Gabby He…

376. Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/virtual_patient_advocate_to_reduce_ambulatory_adverse_drug_events_2010_pdf__2.pdf
     January 01, 2010 - Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events 1 | Virtual Patient adVocate to reduce ambulatory adVerse drug eVents 2010 Grant Summary Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events Principal Investigator: Jack, Brian, M.D. Organization: Boston Medical Center Mechani…

377. Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/2011_017196_jack_pdf_3.pdf
     January 01, 2011 - Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events 1 | Virtual Patient adVocate to reduce ambulatory adVerse drug eVents AmbulAtory SAfety And QuAlity: enAbling PAtient-Centered CAre through heAlth it (r18) Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events Principal Investigator: …

378. Slide 1 (ppt file)
     digital.ahrq.gov/sites/default/files/docs/implementation/Kall%205-II.ppt
     June 05, 2006 - Slide 1 Socio-Technical Approach to Planning and Assessing Redesign l June 5, 2006 l * AHRQ 2006 Annual Conference on Patient Safety and Health IT Socio-Technical Approach to Planning and Assessing Redesign Huron Hospital CPOE Implementation June 5, 2006 Greg Kall, CPHIMS Regional Vice President, Information Te…

379. Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/improving-allergy-documentation-and-clinical-decision-support-electronic-health/citation/understanding
     January 01, 2024 - Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study. Citation Samarakoon U, Wolfson AR, Zhou L, Bassir F, Phillips E, Kroshinsky D, Cucka B, Biglione B, Phadke NA, Jaggers J, Byrne EC, Judd AD, Blumenthal KG. Understanding the patient expe…

380. Data Collection Form | Digital Healthcare Research
     digital.ahrq.gov/document-type/data-collection-form
     January 01, 2023 - Data Collection Form ADE Incident Identification Form Description This form identifies an adverse drug event using data reported by a clinician. Document Source Statewide Implementation of Electronic Health Records ADE and Near Mis…